{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?max-ddpModified.=2019-03-04T23%3A05%3A24.634Z&AnswerDate=2019-03-06&publisher.prefLabel=House+of+Commons", "items" : [{"_about" : "http://data.parliament.uk/resources/1081701", "AnsweringBody" : [{"_value" : "Department for International Trade"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081701/answer", "answerText" : {"_value" : "
This Government frequently discusses human rights and raises concerns with the Saudi Arabian Government. No aspect of our commercial relationship with Saudi Arabia prevents us from speaking frankly and openly about human rights and we use our engagement to encourage reform. We do not pursue trade to the exclusion of human rights.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4016", "label" : {"_value" : "Biography information for Sir George Hollingbery"} } , "answeringMemberConstituency" : {"_value" : "Meon Valley"} , "answeringMemberPrinted" : {"_value" : "George Hollingbery"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T11:08:28.343Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "202"} , "answeringDeptShortName" : {"_value" : "International Trade"} , "answeringDeptSortName" : {"_value" : "International Trade"} , "date" : {"_value" : "2019-03-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Overseas Trade: Saudi Arabia"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Trade, what assessment he has made of Saudi Arabia's record on the maintenance of human rights in determining his policy on future trade with Saudi Arabia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "227994"} , {"_about" : "http://data.parliament.uk/resources/1081702", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081702/answer", "answerText" : {"_value" : "
No such assessment has been made.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:26:30.147Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of NICE guidance on timelines for hyperglycaemia before the provision of additional treatment in order to reduce clinical inertia among type 1 diabetes patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "227995"} , {"_about" : "http://data.parliament.uk/resources/1081703", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081703/answer", "answerText" : {"_value" : "
As health is a devolved matter, it would be for the relevant Department in Northern Ireland to provide information on the improvement of insulin initiation in primary care throughout Northern Ireland.<\/p>
Clinical inertia does not arise in the same way for type 1 diabetes or have the same known body of evidence as that for type 2 diabetes. People with type 1 diabetes require standard treatment with insulin and doses will be adjusted as appropriate to the clinical presentation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:28:44.087Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps are being taken to (a) improve insulin initiation in primary care throughout Northern Ireland and (b) reduce clinical inertia among type 1 diabetes patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "227996"} , {"_about" : "http://data.parliament.uk/resources/1081704", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081704/answer", "answerText" : {"_value" : "
NHS England is developing a diabetes management and care programme aimed at reducing variation and improving outcomes for people with diabetes.<\/p>
<\/p>
NHS England is making an additional £44 million Transformation Funding available to support delivery of the programme which will focus on four areas: reducing variation in the achievement of the three National Institute for Health and Care Excellence treatment targets, improving take up of structured education, improving access to multi-disciplinary foot care teams for people with diabetic foot disease and improving access to specialist inpatient support. The funding will also provide wider support for diabetes improvement, including dedicated diabetes posts in regional teams and clinical networks.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "228000"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:30:58.54Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of people with Type 1 diabetes who meet NICE-recommended blood glucose targets in order to reduce the (a) incidence and (b) cost of complications among people with that type of diabetes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"} } , "tablingMemberConstituency" : {"_value" : "Strangford"} , "tablingMemberPrinted" : [{"_value" : "Jim Shannon"} ], "uin" : "227997"} , {"_about" : "http://data.parliament.uk/resources/1081705", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081705/answer", "answerText" : {"_value" : "
NHS England issued advice in January 2018 to support specialist diabetes staff and primary care staff to effectively manage and support relevant type 1 diabetes patients to avoid and reduce the incidence of hypoglycaemia. The advice can be accessed at the following link:<\/p>